About Auronext Pharma Private Limited
Data last updated:
Auronext Pharma Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Aurobindo Pharma Ltd. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 July 2009.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2009PTC109591. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹255 Cr and a paid-up capital of ₹124.98 Cr. It was led by directors including Jacob Joseph (Whole-Time Director) and Madan Mohan Reddy Mettu.
Its last annual general meeting (AGM) was held on 19 June 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at Galaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032.
As per the financials filed for FY 2023, the company reported a revenue of ₹75.75 Lakh, a growth of 23% compared to the previous year. For the same year it recorded a net loss of ₹3.45 Cr (net margin -455.7%) and EBITDA of -₹3.27 Cr (EBITDA margin -431.3%). Revenue has declined at a compounded annual rate (CAGR) of 90% over three years and 65% over five years.
The company had about 293 employees on its provident fund (EPFO) records before it was dissolved.
The company was associated with 2 brands: Auronext Pharma and Aurobindo Pharma. As per MCA filings, the company had satisfied charges of ₹36.5 Cr on record. The company has 8 deals on record (6 funding rounds, 2 secondary share transfers), with disclosed funding of ₹132.64 Cr; the latest was in March 2020. Its 10 peer companies in the Pharma industry (API Manufacturers, Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Arigos Pharmaceutical Private Limited with revenue of ₹76.52 Lakh. The company has 2 MSME Form 1 returns on record between 2019 and 2020, listing 3 overdue payments to 3 micro and small suppliers.
The last known website on record is aurobindo.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressGalaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032
- IndustryPharma, Drug Formulation & Development, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Auronext Pharma Private Limited
The main business activity of Auronext Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Auronext Pharma Private Limited FY 2023 filings available
Auronext Pharma Private Limited reported revenue of ₹75.75 Lakh (up 23% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Auronext Pharma Private Limited
Revenue rose 23% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 65%. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Auronext Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹75.75 Lakh | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹3.27 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.45 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Auronext Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -431.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -455.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Auronext Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Auronext Pharma Private Limited
Auronext Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Arigos Pharmaceutical Private Limited | ₹76.52 Lakh (FY 2023) | •••• | •••• | •••• | Cachar, Assam, India | |
| Cadomax Healthcare Private Limited | ₹76.23 Lakh (FY 2019) | •••• | •••• | -7.0% | •••• | Davanagere, Karnataka, India |
| Pride Lifescience Private Limited | ₹75.98 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | Sanand, Gujarat, India |
| Good Luck Pharma Private Limited | ₹75.93 Lakh (FY 2025) | •••• | •••• | 7.0% | •••• | Uttar Pradesh, India |
| Organic Medicare Private Limited | ₹75.76 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Kolkata, West Bengal, India |
| Auronext Pharma Private Limited this company | ₹75.75 Lakh (FY 2023) | •••• | •••• | 23.0% | •••• | Hyderabad, Telangana, India |
| Bharavi Pharmaceuticals Limited | ₹75.7 Lakh (FY 2024) | •••• | •••• | 2.0% | •••• | Vadodara, Gujarat, India |
| TGB Biosciences Private Limited | ₹75.66 Lakh (FY 2024) | •••• | •••• | 6.0% | •••• | Bangalore, Karnataka, India |
| Astrabio Lifecare Private Limited | ₹75.65 Lakh (FY 2025) | •••• | •••• | 63.0% | •••• | Pune, Maharashtra, India |
| Presum Pharma Private Limited | ₹75.64 Lakh (FY 2024) | •••• | •••• | 7.0% | •••• | Katihar, Bihar, India |
| Troge Scientific Research India Private Limited | ₹75.63 Lakh (FY 2025) | •••• | •••• | -3.0% | •••• | Gurgaon, Haryana, India |
Peers are the five companies nearest above and the five nearest below Auronext Pharma by revenue in the Pharma industry (API Manufacturers, Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Auronext Pharma Private Limited
Auronext Pharma Private Limited is audited by G P M & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G P M & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors and KMP of Auronext Pharma Private Limited
Auronext Pharma Private Limited currently reports 4 directors and 1 key managerial person. 13 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madan Mohan Reddy Mettu Also directs: MSS Packaging Industries LLP, Aurobindo Pharma Ltd, Engenra Biologics Private Limited and 5 more | Director | 31 Aug 2020 | 6 Years 1 Months | As last reported |
| Sapna Also directs: Aurigene Pharmaceutical Services Limited | Director | 23 May 2019 | 7 Years 4 Months | As last reported |
| Jacob Joseph | Whole-Time Director | 01 Jul 2021 | 5 Years 3 Months | As last reported |
| Venkata Radhakrishna Racharla | Company Secretary | 15 Apr 2019 | 7 Years 5 Months | As last reported |
| Sarath Chandra Reddy Penaka Also directs: Aurobindo Pharma Ltd, Sarath Penaka Enterprises LLP, Naqsh Global Ventures LLP and 5 more | Director | 20 Aug 2009 | 17 Years 1 Months | As last reported |
Ownership and Shareholding of Auronext Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Auronext Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jul 2016 | Yes Bank Limited | ₹35 Cr | Satisfied |
| 02 Feb 2010 | Axis Bank Limited | ₹1.5 Cr | Satisfied |
Total charge records: 2 View all charges
Deals & Funding of Auronext Pharma Private Limited
Auronext Pharma Private Limited has 8 deals on record (6 funding rounds, 2 secondary share transfers), with disclosed funding of ₹132.64 Cr; the latest was in March 2020.
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Secondary share transfer | Undisclosed | Seller: Aurobindo Pharma Ltd |
| Sep 2015 | Secondary share transfer | Undisclosed | Buyer: Aurobindo Pharma Ltd , an individual Seller: 3 individuals |
| Jan 2012 | Funding round | ₹12.66 Cr | Investors: Aurobindo Pharma Ltd , 3 individuals |
| Feb 2011 | Funding round | ₹9.88 Cr | Investors: Aurobindo Pharma Ltd , 3 individuals |
| Apr 2010 | Funding round | ₹6.16 Cr | Investors: Aurobindo Pharma Ltd , 3 individuals |
Full deal history
All 8 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
MSME Payment Delays by Auronext Pharma Private Limited
Auronext Pharma Private Limited has 2 MSME Form 1 returns on record between 2019 and 2020, listing 3 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| MK Teknology1 Private Limited | •••• | •••• | •••• |
| Sri Maruti Packagings | •••• | •••• | •••• |
| Electrolab (India) Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Auronext Pharma Private Limited
Auronext Pharma operates two associated brands: Auronext Pharma and Aurobindo Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Generic biocatalytic solutions are provided for pharmaceutical applications. | aurobindo.com | |
| Offers comprehensive outsourced API production services for the pharmaceutical industry. | auronext.com |
Employees and EPFO Compliance at Auronext Pharma Private Limited
Auronext Pharma Private Limited has a workforce of 293 employees as of Apr 05, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Auronext Pharma Private Limited
Auronext Pharma has one previous CIN (Corporate Identification Number): U74999DL2009PTC191842. The current CIN is U74999TG2009PTC109591, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74999TG2009PTC109591 | Current |
| U74999DL2009PTC191842 | Previous |
News related to Auronext Pharma Private Limited
Recent Activity on Auronext Pharma Private Limited
Auronext Pharma Private Limited has 18 board changes on record since 2009: 5 appointments and 13 cessations. The latest: Madan Mohan Reddy Mettu ceased to be Additional Director on 24 Aug 2021.
15 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Auronext Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Auronext Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Auronext Pharma Private Limited
Auronext Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Auronext Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Auronext Pharma Private Limited
Auronext Pharma has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Auronext Pharma was a private limited company based in Hyderabad, Telangana, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 02 July 2009 and is registered under CIN U74999TG2009PTC109591. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Auronext Pharma was incorporated on 02 July 2009. It is registered with the Registrar of Companies, Hyderabad.
Auronext Pharma had 5 directors and KMP:
- Jacob Joseph - Whole-Time Director
- Madan Mohan Reddy Mettu - Director
- Sapna - Director
- Sarath Chandra Reddy Penaka - Director
- Venkata Radhakrishna Racharla - Company Secretary
The CIN (Corporate Identification Number) of Auronext Pharma is U74999TG2009PTC109591. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Auronext Pharma is at Galaxy Floors 22 – 24 Plot No. 1 Survey No. 831 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032.
Auronext Pharma can be reached through the website aurobindo.com. Its registered office is in Hyderabad, Telangana, India.
Auronext Pharma reported revenue of ₹75.75 Lakh for FY 2023 (up 23% YoY).
Auronext Pharma has an authorised share capital of ₹255 Cr and a paid-up capital of ₹124.98 Cr.
Auronext Pharma reported a net loss of ₹3.45 Cr (net margin -455.7%) and EBITDA of -₹3.27 Cr (EBITDA margin -431.3%) for FY 2023, as per its filed financial statements.
No. Auronext Pharma has 1 GST registration on record and it is cancelled or inactive.
Auronext Pharma operated in the pharma industry, in the drug formulation and development segment.